Malecare launches Cancergraph, a Quality of Life mobile app recording. It's free on the iOS Apple App store, right now! Go to the App store on your iPhone or Download here https://itunes.apple.com/us/app/cancergraph/id1114343314?mt=8 Android coming in November. Cancergraph tracks your cancer symptoms and side effects over days, months and years. Designed by cancer survivors and caregivers, [...]
There are a few things you should know about penile implants if you are considering having one to treat your erectile dysfunction. First you should know that there are actually two different types of implants available, inflatable implants and semi-rigid rods. The inflatable implants have two different design options; they come in either a two- [...]
According to a press release from the Decatur Memorial Hospital in Decatur Ill., after their having completed a clinical trial evaluating C-11 Choline PET CT and in men who have suffered a biochemical relapse of prostate cancer, they are now offering the C-11 Choline PET CT commercially. C-11 Choline uses an FDA approved tracer which, [...]
The possibility of having incontinence as a side effect from all of the primary prostate cancer treatments is significant. Incontinence is not an either or thing as the degree of incontinence varies from individual to individual. Those men having significant levels of inconvenience find that their quality of life is significantly damaged in some cases [...]
I recently returned home from the American Association of Cancer Researchers (AACR) annual meeting held in New Orleans, La. The meeting was, as usual fantastic, but this years conclusion was by far the best I have experienced. The meeting’s closing session was reserved for remarks about the cancer "moonshot" initiative from Vice President Joe Biden. [...]
There has been a lot of hype and confusion about what is the best contrast for prostate cancer PET/CT scans. The two newest contrasts; (18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) and (11)C-choline both have their supporters and their detractors. To try and evaluate the efficacy differences between these two contrasts in men who have suffered a bio-chemical recurrence [...]
According to an article in the Journal of Nuclear Medicine, researchers compared a PET/CT scan using the radiotracer F-18 DCFBC to conventional imaging modalities — an expanded Tc-99m-methylene diphosphonate (MDP) bone scan and contrast-enhanced CT of the chest, abdomen and pelvis — to detect prostate-specific membrane antigen (PSMA), which is associated with prostate cancer metastases. [...]
On October 27, 2015, Malecare was issued patent 9,168,002 for a device and method for real time simultaneous measurement of radiation at specific parts of your body,. Understanding cumulative radiation exposure in people undergoing ionizing radiation for diagnostics and medical treatment is essential towards reducing secondary tumors from primary radiation therapy. We believe that the [...]
Having been diagnosed with prostate cancer does not make you immune to developing another cancer. Look specifically at me; I have now been diagnosed with five different, primary cancers. Not only do we remain susceptible to developing another, unrelated primary cancer, we also are at an increased risk of developing a secondary cancer that is [...]
Radium-223 dichloride (Xofigo) has been approved as an intravenous radiotherapy for men with castration-resistant prostate cancer (CRPC) who have multiple osseous (bone) metastases. Most often, it is used in men who have too many metastases to treat with spot radiation. Xofigo works by mimicking calcium that is attracted to bones. To be successful the drug [...]
